[CAS NO. 20559-16-4]  LysoPC(14:0/0:0)

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [20559-16-4]

Catalog
HY-113123
Brand
MCE
CAS
20559-16-4

DESCRIPTION [20559-16-4]

Overview

MDLMFCD00036902
Molecular Weight467.58
Molecular FormulaC22H46NO7P
SMILESCCCCCCCCCCCCCC(OC[C@@H](O)COP(OCC[N+](C)(C)C)([O-])=O)=O

For research use only. We do not sell to patients.

Summary

LysoPC(14:0/0:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. LysoPC(14:0/0:0) has potent antispasmodic effect [1] .


IC50 & Target

Human Endogenous Metabolite


In Vivo

Of the saturated fatty acid-containing L-α-lysolecithins (LPC), palmitoyl-LPC shows the strongest antispasmodic effect against acetylcholine- or histamine-induced guinea pig ileum contraction; the order of potency of the others is (LysoPC(14:0/0:0)) myristoyl- > stearoyl-, lauroyl- > decanoyl-LPC. Incorporation of a cis-double bond into the C18 fatty acid chain of LPC resulted in a slight decrease of the antispasmodic effect [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

Ethanol : 50 mg/mL ( 106.93 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.1387 mL 10.6934 mL 21.3867 mL
5 mM 0.4277 mL 2.1387 mL 4.2773 mL
10 mM 0.2139 mL 1.0693 mL 2.1387 mL
* Please refer to the solubility information to select the appropriate solvent.


Synonyms

3,5,9-Trioxa-4-phosphatricosan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (7R)-
Choline, hydroxide, dihydrogen phosphate, inner salt, 3-ester with 1-monomyristin, L-
3,5,9-Trioxa-4-phosphatricosan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (R)-
Myristin, 1-mono-, 3-(dihydrogen phosphate), monoester with choline hydroxide, inner salt, L-
Myristoyl L-α-lysolecithin
L-α-Myristoyllysophosphatidylcholine
1-Tetradecanoyl-sn-glycero-3-phosphorylcholine
1-Myristoyl-L-α-phosphorylcholine
1-Myristoyl-sn-glycero-3-phosphatidylcholine
Myristoyl L-α-lysophosphatidylcholine
1-Myristoyl-sn-glycero-3-phosphocholine
Coatsome MC 40H
M-LysoPC
1-Myristoyl-2-hydroxy-sn-glycero-3-phosphocholine
1-Tetradecanoyl-sn-glycero-3-phosphocholine
Lysophosphatidylcholine (14:0)
LysoPC(14:0)
Lysophosphatidylcholine C14:0
LPC 14:0
[(2R)-2-Hydroxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate